India's Ipca to File in U.S. for Six New Drugs by December

India's Ipca Laboratories Ltd. said it will file six abbreviated new drug applications (ANDAs) with the U.S. Food and Drug Administration by December, and it expects exports to rise. The firm, which specialises in cardio-vascular drugs, will file three ANDAs over the next three months, A.K. Jain, executive director at Ipca, told a generics conference in Bombay.

Yahoo News (http://in.news.yahoo.com/050310/137/2k3bz.html)